TABLE 1.
COVID‐19 convalescent plasma characteristics
| Case | Supplier | DONOR | PRODUCT | ADMINISTRATION | |||||
|---|---|---|---|---|---|---|---|---|---|
| Evidence of prior COVID‐19 infection | Days symptom free at donation | SARS‐CoV2 IgG |
SARS‐CoV2 RT‐PCR |
Infusion duration (minutes) | Volume (mL) | Reaction | |||
| Result (OD) | Titer | ||||||||
| 1 | Stanford | NP PCR | 14‐28 | Positive (1.19) | >1:400 | Negative | 146 | 214 | No |
| 2 | Stanford | NP PCR | >28 | Positive (1.63) | >1:400 | Negative | 124 | 207 | No |
| 3 | American Red Cross | Not documented | >28 | Not done | Not done | Not done | 101 | 208 | No |
| 4 | Stanford | NP PCR | >28 | Positive (0.74) | >1:400 | Negative | 120 a | 206 | No |
Abbreviations: NP PCR, nasopharyngeal PCR; OD, optical density.
a
Estimated infusion time.